About DC Pulmonary Medicine
Clinical Trials at DC Pulmonary Medicine
During the past decade, DC Pulmonary Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "DC Pulmonary Medicine"
#1 collaborator was "HealthCore-NERI" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at DC Pulmonary Medicine
According to Clinical.Site data, the most researched conditions in "DC Pulmonary Medicine" are
"Pulmonary Disease, Chronic Obstructive" (2 trials). Many other conditions were trialed in "DC Pulmonary Medicine" in a lesser frequency.
Clinical Trials Intervention Types at DC Pulmonary Medicine
Most popular intervention types in "DC Pulmonary Medicine" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Fluticasone propionate" (1 trials), "ICS (Inhaled Corticosteroid) (Triple therapy)" (1 trials), "LABA (Long-Acting Beta Agonist) (Triple therapy)" (1 trials), "LAMA (Long-Acting Muscarinic Antagonist) (Triple therapy)" (1 trials) and "Olodaterol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at DC Pulmonary Medicine
The vast majority of trials in "DC Pulmonary Medicine" are
2 trials for "All" genders.
Clinical Trials Status at DC Pulmonary Medicine
Currently, there are NaN active trials in "DC Pulmonary Medicine".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in DC Pulmonary Medicine,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in DC Pulmonary Medicine, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".